The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research

Biotechnic and Histochemistry

Volumn 87, Issue 1, 2012, Pages 14-17

  Hicks, D G ^a   Boyce, B F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Breast cancer; Cold ischemic time

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BREAST TUMOR; CHEMISTRY; COLD ISCHEMIA; DIAGNOSTIC ERROR; FEMALE; HISTOLOGY; HUMAN; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; QUALITY CONTROL; STANDARD; TISSUE FIXATION; TRANSLATIONAL RESEARCH;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; COLD ISCHEMIA; DIAGNOSTIC ERRORS; FEMALE; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; PATHOLOGY, SURGICAL; QUALITY CONTROL; REFERENCE STANDARDS; SPECIMEN HANDLING; TISSUE FIXATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 83755205824     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2011.591832     Document Type: Article

References (14)

1. Cross SS, Start RD, Smith JH (1990) Does delay in fi xation affect the number of mitotic fi gures in processed tissue? J. Clin. Pathol. 43: 597-599. (Pubitemid 20203722)
2. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA (2002) Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am. J. Pathol. 161: 1743-1748. (Pubitemid 35265532)
3. Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA (2009) Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteom. Clin. Appl. 3:874-882.
4. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/ College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28: 2784-2795.
5. Hewitt SM, Lewis FA, Cao Y, Conrad RC, Cronin M, Danenberg KD, Goralski TJ, Langmore JP, Raja RG, Williams PM, Palma JF, Warrington JA (2008) Tissue handling and specimen preparation in surgical pathology: Issues concerning the recovery of nucleic acids from formalin-fi xed, paraffi n-embedded tissue. Arch. Pathol. Lab. Med. 132: 1929-1935.
6. Hicks DG, Kulkarni S (2008) Trastuzumab as adjuvant therapy for early breast cancer: The importance of accurate human epidermal growth factor receptor 2 testing. Arch. Pathol. Lab. Med. 132: 1008-1015. (Pubitemid 351918709)
7. Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S (2009) Delay to formalin fi xation effect on breast biomarkers. Mod. Pathol. 22: 1457-1467.
8. Miyatake Y, Ikeda H, Michimata R, Koizumi S, Ishizu A, Nishimura N, Yoshiki T (2004) Differential modulation of gene expression among rat tissues with warm ischemia. Exp. Mol. Pathol. 77: 222-230. (Pubitemid 39422623)
9. Medeiros F, Rigl CT, Anderson GG, Becker SH, Halling KC (2007) Tissue handling for genome-wide expression analysis: A review of the issues, evidence and opportunities. Arch. Pathol. Lab. Med. 131: 1805-1816. (Pubitemid 350294581)
10. Nkoy FL, Hammond ME, Rees W, Belnap T, Rowley B, Catmull S, Sause W (2010) Variable specimen handling affects hormone receptor test results in women with breast cancer: A large multihospital retrospective study. Arch. Pathol. Lab. Med. 134: 606-612.
11. Pinhel IF, Macneill FA, Hills MJ, Salter J, Detre S, A'hern R, Nerurkar A, Osin P, Smith IE, Dowsett M (2010) Extreme loss of immunoreactive p-Akt and p-Erk1/2 duringroutine fi xation of primary breast cancer. Breast Cancer Res. Sep 28;12(5):R76. (Epub ahead of print
12. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344: 783-92. (Pubitemid 32222155)
13. Start RD, Flynn MS, Cross SS, Rogers K, Smith JH. (1991) Is the grading of breast carcinomas affected by a delay infi xation? Virchows Arch. A. Pathol. Anat. Histopathol. 419: 475-477.
14. Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG; Members of the Standardization Ad-Hoc Consensus Committee (2008) Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl. Immunohistochem. Mol. Morphol. 16: 513-520.